Paul Kelly - Dec 31, 2022 Form 5 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Paul E. Kelly
Stock symbol
RLMD
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
2/2/2023, 04:00 PM
Previous filing
Dec 20, 2022
Next filing
May 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Gift $0 -6.4K -99.36% $0.00 41 Jul 8, 2021 Common Stock 4.8K $13.80 Direct F1, F2
transaction RLMD Stock Option (right to buy) Gift $0 -19.6K -13.07% $0.00 130K Jul 8, 2021 Common Stock 19.6K $8.80 Direct F1, F3
transaction RLMD Stock Option (right to buy) Gift $0 -56K -37.33% $0.00 94K Jul 8, 2021 Common Stock 56K $43.47 Direct F1, F4
transaction RLMD Stock Option (right to buy) Gift $0 -18K -12% $0.00 132K Jul 8, 2021 Common Stock 18K $33.43 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust.
F2 The options were granted on November 12, 2015. 25% of the options vested one year from the grant date and the remaining 75% of the options vested in equal quarterly increments of 6.25% of the initial option grant over the following three year period.
F3 The options were granted on July 29, 2019. 6.25% of the options vest each quarter from the date of grant.
F4 The options were granted on December 19, 2019. 6.25% of the options vest each quarter from the date of grant.
F5 The options were granted on January 7, 2021. 6.25% of the options vest each quarter from the date of grant.